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Background
Chronic kidney disease and obesity is characterized by inflammatory pathophysiology.
•
•

Chronic Kidney Disease is characterized by inflammation and proteinuria, decreased GFR, glomerular
sclerosis and progressive loss of renal function.
Obesity is associated with subclinical inflammation and increased levels of circulating CRP, and IL-6.

Maternal obesity and kidney outcome in their children in humans.
•

•

Epidemiological studies have shown maternal obesity during gestation is associated with small-for-birthweight kidney in the newborn, susceptibility to CKD, and congenital anomalies of the kidney and urinary tract
(CAKUT).
Serum IL-6 is elevated in pregnant obese women. Serum IL-6 levels are 1.5- to 2-fold higher in pregnant
obese women compared to non-obese pregnant women.

Fetal kidney following mid-gestational administration of IL-6 (10 pg/g) to pregnant mice
show accelerated maturation with small kidney
•
•
•
•
•

•

Newborns had lower body weight (p<0.001) and kidney (p<0.001) weights (Fig. -Left).
The reduction in growth was also observed following treatment of metanephros harvested at E13.5 and
grown in vitro with IL-6 (10 pg/mL) or without (saline) for up to 72hrs.
Histomorphometry showed decreased nephrogenic zone width (p=0.039), increased numbers of mature
glomeruli (p=0.002), and pretubular aggregates (p=0.041) (Fig.-Middle).
Immunostaining for podocyte markers showed increased number of mature glomeruli (p<0.001) (Fig.-Middle
below).
RT-qPCR Array analysis of cell-cycle and apoptosis genes also suggested accelerated maturation (Fig.Right)

Systemic inflammation is associated with increased tumor necrosis factor-α, IL-1, IL-6, interferon-γ, etc. Each
of these cytokines plays an important role in the inflammatory response. However, only IL-6 can cross the
placental barrier and enter the fetal compartment.
Mother-to-fetus transfer of IL-6 makes it a unique surrogate to study gestational inflammation.
KEGG Pathway: mmu04110 (Cell cycle)

•

• Increased Palb indicates injury to the glomerular filtration barrier which precedes the onset of proteinuria in
chronic kidney disease.
• Isolated rat glomeruli were treated with IL-6 and change in Palb was determined using video microscopy. IL-6
increased Palb in a dose- dependent manner. Significant increase was noted by IL-6 at 0.01 ng/mL
concentration with maximal effect at 1 ng/mL (P<0.05). Pre-treatment with anti-IL-6 antibody completely
blocked the increase in Palb (P<0.05).

IL-6 caused actin filament rearrangement in podocytes
• Immortalized mouse podocytes were incubated with IL-6 for 1hr and the actin filaments were stained with
Rhodamine-conjugated phalloidin. Images were obtained using a Leica TCS SPE confocal system.
• IL-6 caused actin filament rearrangement leading to the formation of a cortical ring. The more conspicuous
finding was a dose-dependent appearance of “actin dots”. Actin dots represent focal adhesions that suggest
actin bundling next to the plasma membrane.

IL-6 is a prototypic pleiotropic cytokine.
•

IL-6 increased glomerular albumin permeability (Palb) of the glomerular filtration barrier

KEGG Pathway: mmu04630 (JAK-STAT
signaling pathway)

IL-6 crosses the placental barrier during fetal development.
•

Results

Results

The IL-6 receptor is a member of the Class I cytokine receptor super family. It consists of two
transmembrane glycoproteins (IL-6Ra and gp130). IL-6 first binds with IL-6Ra and the complex is presented
to gp130 resulting in signal activation.
IL-6 modulates signaling through the JAK-STAT, PI3K-Akt, Raf–MEK-ERK cascades. PI3K-Akt and ERK
signaling are required for renal organogenesis and adult renal function.

Overarching hypothesis

KEGG Pathway: mmu04210 (Apoptosis)

Western blotting showed IL-6 upregulated JAK2/STAT3 in both fetal kidney and podocyte
Maternal systemic inflammation causes developmental changes and susceptibility to
chronic kidney disease in the offspring.

Objectives
(a) To examine the effect of injection of IL-6 on kidney development during mid-gestation, similar to levels
observed in pregnant obese women, as a specific molecular surrogate of gestational inflammation.
(b) To examine the effect of IL-6 on glomerular filtration barrier.

DNA methylation revealed increased 5methyldeoxycytosine
•
•

Methods
• Pregnant C57BL/6 mice received either normal saline or IL-6 (10 pg/g BW) intraperitoneally on alternate days
from E12.5. Fetal kidneys (E20.5) were removed from uterine horns by dissection and fixed in 10% formalin,
OCT or used to isolate DNA, RNA and protein lysate for the following studies:
• Histomorphometry and immunostaining for podocin and podocalyxin was performed.
• LC-MS analysis of hydrolyzed DNA was performed to evaluate for methylation changes.
• qRT-PCR for cell cycle and apoptosis genes.
• Western blotting for JAK-STAT signaling.
• We used in vitro albumin permeability assay and cultured mouse podocytes to study the effect of IL-6 on
filtration barrier and actin cytoskeleton of the podocyte respectively.

LC-MS showed increased 5-methydeoxycytosine but not 5-hydroxymethylcytosine suggestive of increased
differentiated state.
Representative LC chromatograms of 5-methyl-2'-deoxycytidine (5mdC) and 5-hydroxymethyl-2'deoxycytidine (5hmdC) global methylation in fetal kidney DNA.

Summary & Conclusion
1. Perinatal exposure to IL-6, a surrogate for maternal inflammation, results in accelerated maturation of the
kidney resulting in low birth weight and small kidneys.
2. IL-6 causes injury to the glomerular filtration barrier and podocyte.
3. IL-6 upregulates the JAK2-STAT3 pathway.
The IL-6 mouse model will allows us to study the effects of developmental programming of maternal
obesity on the long-term consequences in adulthood of the progeny.
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